| GSK Pakistan | |
| Trading Name: | GLAXO |
| Traded As: | KSE 100 component |
| Type: | Public |
| Area Served: | Pakistan |
| Key People: | |
| Industry: | Pharmaceutical |
| Revenue: | [1] |
| Revenue Year: | 2022 |
| Income Year: | 2022 |
| Net Income Year: | 2022 |
| Hq Location City: | Karachi |
| Hq Location Country: | Pakistan |
| Assets Year: | 2022 |
| Equity Year: | 2022 |
| Num Employees: | 1,768 |
| Num Employees Year: | 2022 |
| Parent: | GSK |
GlaxoSmithKline (GSK) Pakistan is a Pakistani pharmaceutical company which is a subsidiary of British company GSK.[2] It is the largest pharmaceutical company in Pakistan.
The company started its operations in Pakistan as Glaxo Laboratories Pakistan Ltd and was listed on the Karachi Stock Exchange in 1951.[3]
GSK Pakistan equation was formed when Beecham, Glaxo Welcome and Smith Kline, all having a big name in the pharmaceutical market and that were separate entities before, merged in 2002.[4]
In December 2008, GSK Pakistan acquired operations of Bristol Myers Squibb in Pakistan for approximately .[5]
In December 2010, the company acquired Stiefel Laboratories operations in Pakistan.[6]
In 2015, GlaxoSmithKline Consumer Healthcare Pakistan Limited (GSKCH) was demerged from GlaxoSmithKline Pakistan Limited (GLAXO).[7] In 2016, GSKCH started operations as an independent company. A year later, in 2017, GSKCH got listed on PSX.
GLAXO (GlaxoSmithKline Pakistan Limited) manufactures and markets a wide variety of prescription medicines and vaccines.
GSKCH (GlaxoSmithKline Consumer Healthcare Pakistan Limited) sells over-the-counter medicines and consumer products.